Education
About Us
Working with TipRanks
Follow Us
NFL Biosciences SA (DE:82F)
FRANKFURT:82F
82F Stock Chart & Stats
€1.01
-€0.04(-2.21%)
At close: 4:00 PM EST
€1.01
-€0.04(-2.21%)
Day’s Range― - ―
52-Week Range€0.79 - €1.88
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€13.60M
Enterprise Value€17.29M
Total Cash (Recent Filing)€3.56M
Total Debt (Recent Filing)€72.73K
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Mar 30, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.14
Shares Outstanding12,672,242
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.17
Price to Book (P/B)19.83
Price to Sales (P/S)421000.26
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NFL Biosciences SA News
82F FAQ
What was NFL Biosciences SA’s price range in the past 12 months?
NFL Biosciences SA lowest stock price was €0.79 and its highest was €1.88 in the past 12 months.
What is NFL Biosciences SA’s market cap?
NFL Biosciences SA’s market cap is €13.60M.
When is NFL Biosciences SA’s upcoming earnings report date?
NFL Biosciences SA’s upcoming earnings report date is Mar 30, 2026 which is in 101 days.
How were NFL Biosciences SA’s earnings last quarter?
NFL Biosciences SA released its earnings results on Oct 16, 2025. The company reported -€0.142 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.142.
Is NFL Biosciences SA overvalued?
According to Wall Street analysts NFL Biosciences SA’s price is currently Overvalued.
Does NFL Biosciences SA pay dividends?
NFL Biosciences SA does not currently pay dividends.
What is NFL Biosciences SA’s EPS estimate?
NFL Biosciences SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does NFL Biosciences SA have?
NFL Biosciences SA has 12,672,242 shares outstanding.
What happened to NFL Biosciences SA’s price movement after its last earnings report?
NFL Biosciences SA reported an EPS of -€0.142 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.695%.
Which hedge fund is a major shareholder of NFL Biosciences SA?
Currently, no hedge funds are holding shares in DE:82F
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
NFL Biosciences SA
NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.
Technical Analysis
Nicox SA
―
Advicenne SA
―
Valbiotis SA
―
Theranexus SA
―
Plant Advanced Technologies SA
―